Detection and characterization of variant and modified structures of proteins in blood and tissues by mass spectrometry

Mass Spectrometry Reviews

Volumn 25, Issue 5, 2006, Pages 686-712

  Shimizu, Akira ^a   Nakanishi, Toyofumi ^a   Miyazaki, Ayako ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Cu Zn superoxide dismutase; Hemoglobin; Mass spectrometry; Modified protein; Transthyretin; Variant protein

Indexed keywords

BLOOD; COMPOSITION; COPPER COMPOUNDS; DISEASES; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; TISSUE CULTURE; ZINC COMPOUNDS;

CU/ZN SUPEROXIDE DISMUTASE; MODIFIED PROTEIN; TRANSTHYRETIN; VARIANT PROTEIN;

PROTEINS;

PLASMA PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD; BLOOD ANALYSIS; BLOOD PROTEIN DISORDER; CHEMISTRY; HUMAN; MASS SPECTROMETRY; METHODOLOGY; MOLECULAR GENETICS; PEPTIDE MAPPING;

AMINO ACID SEQUENCE; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEIN DISORDERS; BLOOD PROTEINS; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING;

EID: 33748286881     PISSN: 02777037     EISSN: None     Source Type: Journal    
DOI: 10.1002/mas.20086     Document Type: Article

References (111)

1. Allen DW, Schroeder WA, Balog J. 1958. Observations on the Chromatographic heterogeneity of normal adult and fetal human hemoglobin: A study of the effects of crystallization and chromatography on the heterogeneity and isoleucine content. J Am Chem Soc 80:1628-1634.
2. Ando Y, Nakamura M, Araki S. 2005. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62:1057-1062.
3. Ando Y, Ohlsson PI, Suhr O, Nyhlin N, Yamashita T, Holmgren G, Danielsson A, Sandgren O, Uchino M, Ando M. 1996. A new simple and rapid screening method for variant transthyretin-related amyloidosis. Biochem Biophys Res Commun 228:480-483.
4. Arisato T, Okubo R, Arata H, Abe K, Fukada K, Sakoda S, Shimizu A, Qin XH, Izumo S, Osame M, Nakagawa M. 2003. Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families. Acta Neuropathol (Berl) 106:561-568.
5. Bergström J, Gustavsson A, Hellman U, Sletten K, Murphy CL, Weiss DT, Solomon A, Olofsson BO, Westermark P. 2005. Amyloid deposits in transthyretin-derived amyloidosis: Cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 206(2):224-232.
6. Biemann K. 1988. Contributions of mass spectrometry to peptide and protein structure. Biomed Environ Mass Spectrom 16(1-12):99-111.
7. Bry L, Chen PC, Sacks DB. 2001. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 47:153-163.
8. Bunn HF, Haney DN, Gabbay KH, Gallop PM. 1975. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun 67:103-109.
9. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. 2003. Tabulation of human transthyretin (TTR) variants. Amyloid 10:160-184.
10. Cornwell GG III, Sletten K, Johansson B, Westermark P. 1988. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun 154:648-653.
11. Covey TR, Huang EC, Henion JD. 1991. Structural characterization of protein tryptic peptides via liquid chromatography/mass spectrometry and collision-induced dissociation of their doubly charged molecular ions. Anal Chem 63:1193-1200.
12. Dwulet FE, Benson MD. 1983. Polymorphism of human plasma thyroxine binding prealbumin. Biochem Biophys Res Commun 114:657-662.
13. Ebert C, Ebert G, Rossmeissl G. 1977. On the specific cleavage of cysteine containing peptides and proteins. Adv Exp Med Biol 86B:205-211.
14. Falick AM, Shackleton CH, Green BN, Witkowska HE. 1990. Tandem mass spectrometry in the clinical analysis of variant hemoglobins. Rapid Commun Mass Spectrom 4:396-400.
15. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science 246: 64-71.
16. Finke A, Kobold U, Hoelzel W, Weykamp C, Miedema K, Jeppsson JO. 1998. Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med 36:299-308.
17. Friedman M. 1999a. Chemistry, biochemistry, nutrition, and microbiology of lysinoalanine, lanthionine, and histidinoalanine in food and other proteins. J Agric Food Chem 47:1295-1319.
18. Friedman M. 1999b. Lysinoalanine in food and in antimicrobial proteins. Adv Exp Med Biol 459:145-159.
19. Fukada K, Nagano S, Satoh M, Tohyama C, Nakanishi T, Shimizu A, Yanagihara T, Sakoda S. 2001. Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice. Eur J Neurosci 14:2032-2036.
20. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. 1989. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: Immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 83:836-843.
21. Green BN, Oliver RWA, Falick AM, Shackleton CHL, Roitman E, Witkowska HE. 1990. Electrospray MS, LSIMS and MS/MS for the rapid detection and characterization of variant hemoglobins. In: Burlingame AL, McCloskey JA, editors. Biological Mass Spectrometry. Amsterdam, The Netherlands: Elsevier Science B. V. pp 129-146.
22. Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. 2002. HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 19(3):225-233.
23. Havir EA, Hanson KR. 1975. L-phenylalanine ammonia-lyase (maize, potato, and Rhodotorula glutinis). Studies of the prosthetic group with nitromethane. Biochemistry 14:1620-1626.
24. Herbert B, Hopwood F, Oxley D, McCarthy J, Laver M, Grinyer J, Goodall A, Williams K, Castagna A, Righetti PG. 2003. Beta-elimination: An unexpected artefact in proteome analysis. Proteomics 3(6):826-831.
25. Herrmann W. 2001. The importance of hyperhomocysteinemia as a risk factor for diseases: An overview. Clin Chem Lab Med 39:666-674.
26. Iguchi K, Nakanishi T, Miyazaki A, Shimizu A, Ota A. 2004. Development of an isotope dilution mass spectrometry assay for HbA1c based on enzyme-cleaved peptide analysis. J Chromatogr B 806:25-31.
27. Ikeda S, Tokuda T, Nakamura A, Ueno I, Taketomi T, Yanagisawa N, Li YF. 1997. Transthyretin Met30 familial amyloid polyneuropathy in China. Usefulness of mass spectrometry for screening a variant TTR in serum. Amyloid: Int J Exp Clin Invest 4:104-107.
28. Ingram VM. 1956. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 178:792-794.
29. Jacobsson J, Jonsson PA, Andersen PM, Forsgren L, Marklund SL. 2001. Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations. Brain 124:1461-1466.
30. Jaeken J. 2003. Congenital disorders of glycosylation (CDG): It's all in it! J Inherit Metab Dis 26(2-3):99-118.
31. Jaeken J, Matthijs G, Carchon H, Van Schafitingen E. 2001. Defects of N-glycan synthesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic & molecular basis of inherited disease. New York, USA: McGraw-Hill Medical Publishing Division, pp 1601-1622.
32. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C. 2002. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40:78-89.
33. Kanda Y, Goodman DS, Canfield RE, Morgan FJ. 1974. The amino acid sequence of human plasma prealbumin. J Biol Chem 249(21):6796-6805.
34. Kano G, Morimoto A, Hibi S, Tokuda C, Todo S, Sugimoto T, Harano T, Miyazaki A, Shimizu A, Imashuku S. 2004. Hb Bristol-Alesha presenting thalassemia-type hyperunstable hemoglobinopathy. Int J Hematol 80:410-415.
35. Karas M, Hillenkamp F. 1988. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 60(20):2299-2301.
36. Kishikawa M, Nakanishi T, Miyazaki A, Shimizu A, Nakazato M, Kangawa K, Matsuo H. 1996. Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by high-performance liquid chromatography/electrospray ionization mass spectrometry using material precipitated with specific antiserum. J Mass Spectrom 31:112-114.
37. Kishikawa M, Nakanishi T, Miyazaki A, Hatanaka M, Shimizu A, Tamoto S, Ohsawa N, Hayashi H, Kanai M. 1998. A new nonamyloid transthyretin variant, G101S, detected by electrospray ionization/Mass Spectrometry. Mutations in brief no201. Online. Hum Mutat 12: 363.
38. Kishikawa M, Nakanishi T, Miyazaki A, Shimizu A, Kusaka H, Fukui M, Nishiue T. 1999a. A new amyloidogenic transthyretin variant, [D38A], detected by electrospray ionization/Mass Spectrometry. Amyloid 6: 278-281.
39. Kishikawa M, Nakanishi T, Miyazaki A, Shimizu A. 1999b. A simple and reliable method of detecting variant transthyretins by multidimensional liquid chromatography coupled to electrospray ionization mass spectrometry. Amyloid 6:48-53.
40. Kishikawa M, Nakanishi T, Shimizu A, Yoshino M. 2000. Detection by mass spectrometry of highly increased amount of S-sulfonated transthyretin in serum from a patient with molybdenum cofactor deficiency. Pediatr Res 47:492-494.
41. Kishikawa M, Sass JO, Sakura N, Nakanishi T, Shimizu A, Yoshioka M. 2002. The peak height ratio of S-sulfonated transthyretin and other oxidized isoforms as a marker for molybdenum cofactor deficiency, measured by electrospray ionization mass spectrometry. Biochim Biophys Acta 1588:135-138.
42. Kobold U, Jeppsson JO, Dulffer T, Finke A, Hoelzel W, Miedema K. 1997. Candidate reference methods for hemoglobin Ale based on peptide mapping. Clin Chem 43:1944-1951.
43. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. 1976. Correlation of glucose regulation and hemoglobin Ale in diabetes mellitus. N Engl J Med 295:417-420.
44. Lacan P, Souillet G, Aubry M, Prome D, Richelme-David S, Kister J, Wajcman H, Francina A. 2002. New alpha 2 globin chain variant with low oxygen affinity affecting the N-terminal residue and leading to N-acetylation [Hb Lyon-Bron alpha 1(NA1)Val→ Ac-A1a]. Am J Hematol 69:214-218.
45. Lacan P, Becchi M, Zanella-Cleon I, Aubry M, Quinsat D, Couprie N, Francina A. 2005. Identification by mass spectrometry of a hemoglobin variant with an elongated beta globin chain. Clin Chem 51:213-215.
46. Lacey JM, Bergen HR, Magera MJ, Naylor S, O'Brien JF. 2001. Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin Chem 47: 513-518.
47. Lacombe C, Prome D, Blouquit Y, Bardakdjian J, Arous N, Mrad A, Prome JC. Rosa J. 1990. New results of hemoglobin variant structure determinations by fast atom bombardment mass spectrometry. Hemoglobin 14:529-548.
48. Lee TD, Rahbar S. 1991. The mass spectral analysis of hemoglobin variants. In: Desiderio DM, editor. Mass Spectrometry of peptides. Boca Raton, FL: CRC press, pp 257-274.
49. Light-Wahl KJ, Loo JA, Esmonds CG, Smith RD, Witkowska HE, Shackleton CHL, Wu CC. 1993. Collisionally activated dissociation and tandem mass spectrometry of intact hemoglobin-chain variant proteins with electrospray ionization. Biol Mass Spectrom 22:112-120.
50. Lim A, Prokaeva T, McComb ME, O'Connor PB, Theberge R, Connors LH, Skinner M, Costello CE. 2002. Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis. Anal Chem 74:741-751.
51. Lim A, Sengupta S, McComb ME, Theberge R, Wilson WG, Costello CE, Jacobsen DW. 2003. In vitro and in vivo interactions of homocysteine with human plasma transthyretin. J Biol Chem 278:49707-49713.
52. Matsuo T, Matsuda H, Katakuse I. 1979. Silicon emitter for field desorption mass spectrometry. Anal Chem 51:69-72.
53. Matsuo T, Matsuda H, Katakuse I, Wada Y, Fujita T, Hayashi A. 1981. Field desorption mass spectra of tryptic peptides of human hemoglobin chains. Biomed Mass Spectrom 8:25-30.
54. Medina M, Urdiales JL, Amores-Sanchez MI. 2001. Roles of homocysteine in cell metabolism: old and new functions. Eur J Biochem 268:3871-3882.
55. Miyazaki A, Nakanishi T, Kishikawa M, Shimizu A, Ohba Y, Tanaka A, Sasaki H. 1996. Post-translational modification from methionine to aspartic acid-residue on a variant hemoglobin, Hb Bristol, a proof by ESI-MS-MS. J Mass Spectrom 31:1311-1313.
56. Miyazaki A, Nakanishi T, Kishikawa M, Shimizu A, Jozaki K, Yonezawa T. 1997. The first Japanese case of Hb Santa Ana, an unstable abnormal hemoglobin, identified rapidly by electrospray ionization mass spectrometry. Intern Med 36:365-370.
57. Miyazaki A, Nakanishi T, Kishikawa M, Nakagawa T, Shimizu A, Mawjood AH, Imai K, Aoki Y, Kikuchi M. 1999. Compound heterozygosity for beta(+)-thalassemia [-31 (A →G)] and a new variant with low oxygen affinity, Hb Sagami [beta139(H17)Asn → Thr]. Hemoglobin 23:267-271.
58. Miyazaki A, Nakanishi T, Shimizu A, Hisamitsu H. 2003a. The first case of a single heterozygote of an abnormal hemoglobin, Hb Stanmore, [β111(G13)Val → A1a]. J Chromatogr B 792:23-31.
59. Miyazaki A, Nakanishi T, Shimizu A, Ninomiya K, Nishimura S, Imai K. 2003b. HB BUZEN [β138(H16)A1a → Thr(g.1395 G→ A)]. Anew β chain variant. Hemoglobin 27:243-247.
60. Miyazaki A, Nakanishi T, Shimizu A, Mizobuchi M, Yamada Y, Imai K. 2005. Hb KOCHI [beta141(H19)Leu → Val (g. 1404 C → G); 144 → 146(HC1-3)Lys-Tyr-His → 0 (g.1413 A → T)]: a new variant with increased oxygen affinity. Hemoglobin 29:1-10.
61. Mudd SH, Levy LH, Kraus JP. 2001. Disorders of transulfuration. New York: McGraw-Hill.
62. Nakanishi T, Iguchi K, Shimizu A. 2003. Method for hemoglobin A(1c) measurement based on peptide analysis by electrospray ionization mass spectrometry with deuterium-labeled synthetic peptides as internal standards. Clin Chem 49:829-831.
63. Nakanishi T, Shimizu A. 1999. Ratio of the ion peak intensity of glycated to non-glycated hexapeptides from the N-terminal of hemoglobin b-chain measured by LC-ESI Mass Spectrometry. J Mass Spectrom Soc Jpn 47:389-391.
64. Nakanishi T, Okamoto N, Tanaka K, Shimizu A. 1994. Laser desorption time-of-flight mass spectrometric analysis of transferrin precipitated with antiserum: A unique simple method to identify molecular weight variants. Biol Mass Spectrom 23:230-233.
65. Nakanishi T, Shimizu A, Okamoto N, Ingendoh A, Kanai M. 1995. Analysis of serum protein precipitated with antiserum by matrix-assisted laser desorption ionization/time-of flight and electrospray ionization Mass Spectrometry as a Clinical Laboratory Test. J Am Soc Mass Spectrom 6:854-859.
66. Nakanishi T, Miyazaki A, Kishikawa M, Shimizu A, Yonezawa T. 1996. Electrospray ionization-tandem Mass Spectrometry analysis of peptides derived by enzymatic digestion of oxidized globin subunits: An improved method to determine amino acid substitution in the hemoglobin core. J Am Soc Mass Spectrom 7:1040-1049.
67. Nakanishi T, Kishikawa M, Miyazaki A, Shimizu A, Ogawa Y, Sakoda S, Ohi T, Shoji H. 1998a. Simple and denned method to detect the SOD-1 mutants from patients with familial amyotrophic lateral sclerosis by Mass Spectrometry. J Neurosci Meth 81:41-44.
68. Nakanishi T, Miyazaki A, Kishikawa M, Shimizu A, Aoki K, Kikuchi M. 1998b. Hb Sagami [beta 139(H17)Asn → Thr]: a new hemoglobin variant not detected by isoelectrofocusing and propan-2-ol test, was detected by electrospray ionization mass Spectrometry. J Mass Spectrom 33:565-569.
69. Nakanishi T, Miyazaki A, Kishikawa M, Shimizu A, Aoki Y, Kikuchi M. 1998c. Hb Peterborough [beta 111(G13)Val → Phe] in Japan; rapid identification by ESI/MS using proteolytic digests of oxidized globin. Hemoglobin 22:23-35.
70. Nakanishi T, Miyazaki A, Kishikawa M, Shimizu A, Kishida O, Sumi S, Tsubakio T, Imai K. 1998d. A new hemoglobin variant found during Hb Ale measurement: Hb Hokusetsu [beta52(D3)Asp → Gly]. Hemoglobin 22:355-371.
71. Nakanishi T, Miyazaki A, Iguchi K, Shimizu A. 2000. Effect of hemoglobin variants on routine glycohemoglobin measurements assessed by a mass spectrometric method. Clin Chem 46:1689-1692.
72. Nakanishi T, Miyazaki A, Shimizu A, Yamaguchi A, Nishimura S. 2002. Assessment of the effect of hemoglobin variants on routine HbA1c measurements by electrospray ionization mass Spectrometry. Clin Chim Acta 323:89-101.
73. Nakanishi T, Sato T, Sakoda S, Yoshioka M, Shimizu A. 2004. Modification of cysteine residue in transthyretin and a synthetic peptide: Analyses by electrospray ionization mass Spectrometry. Biochim Biophys Acta 1698:45-53.
74. Nakazato M, Kishikawa M, Shimizu A. 1998. Twelve abnormal transthyretin in systemic amyloidosis in Japan. In: Kyle RA, Gertz MA, editors. Amyloid and amyloidosis. Minnesota, USA: The Parthenon Publishing Group, pp 315-317.
75. Ogawa K, Bando T, Ogawa M, Miyazaki A, Nakanishi T, Shimizu A. 2003. Hemoglobin variant HbG-Coushatta(β-22 Glu → A1a) found by dissociation of blood glucose from values of HbA1c measured by HPLC. Intern Med 42:781-787.
76. Ohba Y, Miyaji T, Murakami M, Kadowaki S, Fujita T, Oimomi M, Hatanaka H, Ishikawa K, Baba S, Hitaka K, et al. 1986. Hb Himeji or beta 140 (H18) A1a → Asp. A slightly unstable hemoglobin with increased beta N-terminal glycation. Hemoglobin 10:109-125.
77. Ohba Y, Hattori Y, Sakata S, Yamashiro Y, Okayama N, Hirano T, Nakanishi T, Miyazaki A, Shimizu A. 1997. Hb Niigata [beta 1 (NA1) Val → Leu]: The fifth variant with retention of the initiator methionine and partial acetylation. Hemoglobin 21:179-186.
78. Patrinos GP, Giardine B, Riemer C, Miller W, Chui DHK, Anagnou NP, Wajcman H, Hardison RC. 2004. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 32 (Database issue):D537-D541.
79. Pauling L, Itano HA, Singer SJ, Wells I. 1949. Sickle cell anemia a molecular disease. Science 110:543-548.
80. Prehu C, Groff P, Kalmes G, Golinska B, Riou J, Prome D, Richelme-David S, Kiger L, Ducrocq R, Wajcman H. 2003. Short insertion in a hemoglobin chain: Hb Esch, an unstable alphal variant with duplication of the sequence A1a65-Leu-Thr-Asn68. Blood Cells Mol Dis 31:234-239.
81. Rahbar S, Blumenfeld O, Ranney HM. 1969. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 36:838-843.
82. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. 1993. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
83. Rosenblatt D, Fenton WA. 2001. Inherited disorders of folate and cobalamin transport and metabolism. New York: McGraw-Hill.
84. Sass JO, Nakanishi T, Sato T, Sperl W, Shimizu A. 2003. S-homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia. Biochem Biophys Res Commun 310:242-246.
85. Sass JO, Nakanishi T, Sato T, Shimizu A. 2004a. New approaches towards laboratory diagnosis of isolated sulfite oxidase deficiency. Ann Clin Biochem 41:157-159.
86. Sato T, Yamamoto Y, Nakanishi T, Fukada K, Sugai F, Zhou Z, Okuno T, Nagano S, Hirata S, Shimizu A, Sakoda S. 2004b. Identification of two novel mutations in the Cu/Zn Superoxide dismutase gene with familial amyotrophic lateral sclerosis: Mass spectrometric and genomic analyses. J Neurol Sci 218:79-83.
87. Sato T, Nakanishi T, Yamamoto Y, Andersen PM, Ogawa Y, Fukada K, Zhou Z, Aoike F, Sugai F, Nagano S, Hirata S, Ogawa M, Nakano R, Ohi T, Kato T, Nakagawa M, Hamasaki T, Shimizu A, Sakoda S. 2005. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS. Neurology 65:1954-1957.
88. Shackleton CH, Witkowska HE. 1996. Characterizing abnormal hemoglobin by MS. Anal Chem 68:29A-33A.
89. Shimizu A. 2003. Complimentary address to Mr. Koichi Tanaka, the winner of Nobel Prize in chemistry 2002. J Chromatogr B 792:3-4.
90. Shimizu A, Hayashi A, Yamamura Y, Tsugita A, Kitayama K. 1965. The Structural Study On A New Hemoglobin Variant, Hb Mosaka. Biochim Biophys Acta 97:472-482.
91. Shimizu A, Nakanishi T, Kishikawa M, Miyazaki A. 1998. Detection and characterization of aberrant blood proteins by LC/ESI/MS. Adv Mass Spectrom 14:407-421.
92. Shimizu A, Nakanishi T, Kishikawa M, Miyazaki A. 2002. Detection and identification of protein variants and adducts in blood and tissues: An application of soft ionization mass spectrometry to clinical diagnosis. J Chromatogr B 776:15-30.
93. Tanaka K, Waki H, Ido Y, Akita S, Yoshida Y, Yoshida T. 1988. Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2:151-153.
94. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. 1983. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 116:880-888.
95. Theberge R, Connors L, Skinner M, Skare J, Costello CE. 1999a. Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 71:452-459.
96. Theberge R, Connors L, Skare J, Skinner M, Falk RH, Costello CE. 1999b. A new amyloidogenic transthyretin variant (Val 122A1a) found in a compound heterozygous patient. Amyloid 6:54-58.
97. Theberge R, Connors LH, Skinner M, Costello CE. 2000. Detection of transthyretin variants using immunoprecipitation and matrix-assisted laser desorption/ionization bioreactive probes: A clinical application of mass spectrometry. J Am Soc Mass Spectrom 11:172-175.
98. Uemichi T, Murrell JR, Zeldenrust S, Benson MD. 1992. A new mutant transthyretin (Arg 10) associated with familial amyloid poly neuropathy. J Med Genet 29(12):888-891.
99. Wada Y, Hayashi A, Fujita T, Matsuo T, Katakuse I, Matsuda H. 1981. Structural analysis of human hemoglobin variants with field desorption mass spectrometry. Biochim Biophys Acta 667:233-241.
100. Wada Y, Hayashi A, Masanori F, Katakuse I, Ichihara T, Nakabushi H, Matsuo T, Sakurai T, Matsuda H. 1983. Characterization of a new fetal hemoglobin variant, Hb F Izumi A gamma 6Glu replaced by Gly, by molecular secondary ion mass spectrometry. Biochim Biophys Acta 749:244-248.
101. Wada Y, Matsuo T, Katakuse I, Suzuki T, Azuma T, Tsujino S, Kishimoto S, Matsuda H, Hayashhi A. 1986. Mass spectrometric detection of the plasma prealbumin (transthyretin) variant associated with familial amyloidotic polyneuropathy. Biochim Biophys Acta 873:316-319.
102. Wada Y, Matsuo T, Papayannopoulos IA, Costello CE, Biemann K. 1992a. Fast atom bombardment and tandem mass spectrometry for the characterization of hemoglobin variants including a new variant. Int J Mass Spectrom Ion Processes 122:219-229.
103. Wada Y, Nishikawa A, Okamoto N, Inui K, Tsukamoto H, Okada S, Taniguchi N. 1992b. Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. Biochem Biophys Res Commun 15:832-836.
104. Wada Y, Gu J, Okamoto N, Inui K. 1994. Diagnosis of carbohydrate- deficient glycoprotein syndrome by matrix-assisted laser desorption time-of-flight mass spectrometry. Biol Mass Spectrom 23:108-109.
105. Wajeman H, Prehu C, Bardakdjian-Michau J, Prome D, Riou J, Godart C, Mathis M, Hurtrel D, Galacteros F. 2001. Abnormal hemoglobins: Laboratory methods. Hemoglobin 25:169-181.
106. Westermark P, Sletten K, Johansson B, Cornwell GG III. 1990. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87:2843-2845.
107. Weykamp CW, Penders TJ, Muskiet FA, van der Slik W. 1994. Effect of calibration on dispersion of glycohemoglobin values determined by 111 laboratories using 21 methods. Clin Chem 40:138-144.
108. Wild BJ, Bain BJ. 2004. Detection and quantitation of normal and variant haemoglobins: An analytical review. Ann Clin Biochem 41:355-369.
109. Winslow RM, Swenberg ML, Gross E, Chervenick PA, Buchman RR, Anderson WF. 1976. Hemoglobin McKees Rocks (alpha2beta2145Tyr leads to Term). A human "nonsense" mutation leading to a shortened beta-chain. J Clin Invest 57:772-781.
110. Wu SL, Leung D, Tretyakov L, Hu J, Guzzetta A, Wang YJ. 2000. The formation and mechanism of multimerization in a freeze-dried peptide. Int J Pharm 200:1-16.
111. Yoshioka M, Tamura Z. 1971. Bifidus factors in carrot. II. The structure of the factor in fraction IV. Chem Pharm Bull 19:178-185.